Development of Novel Chemically-Modified Nucleic Acid Molecules for Efficient Inhibition of Human <i>MAPT</i> Gene Expression
The hyperphosphorylation of the microtubule-associated protein tau (MAPT) has been implicated in various neurological diseases, including Alzheimer’s disease. It has been hypothesized that the reduction of MAPT would result in depolymerizing neurofibrillary tangles and could be a potential strategy...
Main Authors: | Madhuri Chakravarthy, Suxiang Chen, Tao Wang, Rakesh N. Veedu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/11/6/667 |
Similar Items
-
What’s in a Gene? The Outstanding Diversity of <i>MAPT</i>
by: Daniel Ruiz-Gabarre, et al.
Published: (2022-03-01) -
Recent Advances in Oligonucleotide Therapeutics in Oncology
by: Haoyu Xiong, et al.
Published: (2021-03-01) -
Modified Nucleic Acids: Expanding the Capabilities of Functional Oligonucleotides
by: Steven Ochoa, et al.
Published: (2020-10-01) -
Tau Isoforms: Gaining Insight into <i>MAPT</i> Alternative Splicing
by: Andrea Corsi, et al.
Published: (2022-12-01) -
Tau (MAPT) haplotypes in Jordan: new evidence on the Middle East as a melting-pot predating Neolithic migration
by: Almuthanna K. Alkaraki, et al.
Published: (2021-07-01)